Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Sep 13;5(3):342–353. doi: 10.1016/j.bpsc.2019.08.011

Table 6.

Intraclass correlations indexing test-retest reliability between baseline and posttest values for the N170 amplitude and latency in the treatment (EXP), waitlist control (WLC), and the combined samples. 95% confidence intervals are provided in the parentheses. Shaded cells identify non-significant values.

EXP WLC Combined
left right left right left right
N170 amplitude
Face single 0.72 (.49–.85) 0.73 (.50–.85) 0.73 (.45–.87) 0.53 (.05–.77) 0.72 (.56–.83) 0.66 (.47–.79)
Face repeated 0.58 (.23–.77) 0.81 (.64–.89) 0.70 (.40–.85) 0.57 (.13–.79) 0.63 (.41–.76) 0.72 (.56–.82)
House single 0.76 (.55–.87) 0.78 (.59–.88) 0.71 (.40–.85) 0.53 (.05–.77) 0.74 (.58–.83) 0.68 (.50–.80)
House repeated 0.64 (.33–.80) 0.58 (.22–.77) 0.79 (.57–.89) 0.36 (−.29–.69) 0.70 (.53–.80) 0.47 (.16–.66)
N170 latency
Face single 0.24 (−.40–.59) 0.52 (.11–.74) 0.54 (.08–.77) 0.58 (.14–.79) 0.40 (.05–.62) 0.55 (.30–.72)
Face repeated 0.17 (−.53–.55) 0.49 (.07–.73) 0.64 (.27–.82) 0.59 (.16–.80) 0.36 (−.01–.60) 0.55 (.29–.72)
House single 0.50 (.08–.73) 0.59 (.24–.78) 0.37 (−.27–.69) 0.13 (−.77–.57) 0.44 (.12–.65) 0.44 (.11–.64)
House repeated 0.48 (.03–.72) 0.48 (.03–.72) 0.28 (−.45–.65) 0.40 (−.21–.71) 0.42 (.08–.63) 0.49 (.19–.67)